Vidwan-ID : 163760



  • Dr Mukesh Samant

  • Assistant Professor
  • Kumaun University
Publications 2007 - 2023

Publications

  • 26
    Journal Articles
  • 9
    Book Chapter
  • 15
    Review
  • 3
    Book
  • 2
    Projects
  • 2
  • 3
  • 6

Citations / H-Index

1000 Citations
23 h-index
378 Citations

Altmetrics

44
25
68
1449
23

Co-author Network


Expertise

Microbiology

Life Sciences

Personal Information

Dr Mukesh Samant

Male
Department of Zoology Department of Zoology, Kumaun University
Nainital, Uttarakhand, India - 263001


Experience

  • Assistant Professor

    Department of Zoology

    Kumaun University

  • Assistant Professor (Grade-I)

    Zoology

    Kumaun University

  • Senior Research Fellow

    Parasitology

    CSIR-Central Drug Research Institute

  • Junior Research Fellow

    CSIR-Central Drug Research Institute


Qualification

  • Ph.D.

    CSIR-Central Drug Research Institute

  • M.Sc.

    Govind Ballabh Pant University of Agriculture and Technology


Honours and Awards

2003

CSIR-NET-JRF

CSIR

2003

GATE (98.29 percentile)

IIT Roorkee

2003

CSIR-NET-JRF

CSIR

2003

GATE (98.29 percentile)

IIT Roorkee

Read Less

Doctoral Theses Guided

2020

Evaluation of DDX3 DEAD Box RNA helicase as Drug Target and Genetically Modified Live Attenuated Vaccine Candidate against Protozoan Parasite Leishmania donovani

Mr. Satish Chandra Pandey, Kumaun University

2020

Evaluation of DDX3 DEAD Box RNA helicase as Drug Target and Genetically Modified Live Attenuated Vaccine Candidate against Protozoan Parasite Leishmania donovani

Mr. Satish Chandra Pandey, Kumaun University

Read Less

Membership In Professional Bodies

2009

Centre for Host Parasite Interactions Quebec Canada

Permanent

2009

Centre for Host Parasite Interactions Quebec Canada

Permanent

Read Less

Research Projects

DEAD Box RNA helicase: Putative genetically modified attenuated vaccine candidate or Drug target against Protozoan parasite Leishmania.

Funding Agency : SERB

Evaluation of antigenicity and diagnostic potential of vaccine candidates in human Visceral Leishmaniasis.

Funding Agency : UGC

DEAD Box RNA helicase: Putative genetically modified attenuated vaccine candidate or Drug target against Protozoan parasite Leishmania.

Funding Agency : SERB

Evaluation of antigenicity and diagnostic potential of vaccine candidates in human Visceral Leishmaniasis.

Funding Agency : UGC

Read Less